Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
65,926,694
-
Shares change
-
+685,495
-
Total reported value, excl. options
-
$3,632,531,095
-
Value change
-
+$51,380,893
-
Put/Call ratio
-
97%
-
Number of buys
-
85
-
Number of sells
-
-88
-
Price
-
$55.11
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2021
228 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q2 2021.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65,926,694 shares
.
Largest 10 shareholders include FMR LLC (8,082,010 shares), WELLINGTON MANAGEMENT GROUP LLP (6,769,715 shares), BlackRock Inc. (5,974,507 shares), VANGUARD GROUP INC (5,590,406 shares), JPMORGAN CHASE & CO (5,162,311 shares), Bellevue Group AG (4,352,992 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,983,223 shares), Rock Springs Capital Management LP (2,574,308 shares), Casdin Capital, LLC (2,165,000 shares), and STATE STREET CORP (1,970,059 shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.